Skip to content

INFINITY PHARMA

Inactive
KBO/BCE: BE 0883.273.090

No longer registered with the KBO; last annual accounts for fiscal year 2020.

Signals

Three signals. The signal on the left, the evidence on the right.
neutral
neutral · No filing for years
The last filed financial year closed on 31-12-2020. Since then, 5 financial years are missing. This points to a standstill, not an imminent failure.
NBB · 10 filings
Position against the passed deadline
31-12-2021 close31-07-2022 deadline15-09-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2020 was due by 31-07-2021 and was filed on 25-05-2021, 67 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
not filed
2023
not filed
2022
not filed
2021
not filed
2020
67 d early
2019
61 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2020, full schema

Turnover
€5.82M▲ 11.3%
2019 · €5.23M
2018: €5.10M 2019: €5.23M
2018 → 2020
EBIT margin
6.9%▼ 4.0pp
2019 · 10.9%
2018: 13.5% 2019: 10.9%
2018 → 2020
Net result
€177k▼ 38.9%
2019 · €290k
2018: €394k 2019: €290k
2018 → 2020
Working capital
€1.48M▲ 15.0%
2019 · €1.29M
2018: €977k 2019: €1.29M
2018 → 2020
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line201820192020Trend
Turnover€5.10M-€5.23M▲ 2.6%€5.82M▲ 11.3%
Equity€1.02M-€1.31M▲ 28.5%€1.49M▲ 13.6%
Operating result€690k-€571k▼ 17.3%€405k▼ 29.1%
Net result€394k-€290k▼ 26.4%€177k▼ 38.9%
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2018: €690k€690kNet result 2018: €394k€394kOperating result 2019: €571k€571kNet result 2019: €290k€290kOperating result 2020: €405k€405kNet result 2020: €177k€177k201820192020
The operating result has fallen two years in a row; 2020 is 29% below 2019 and is the lowest year so far.
Balance-sheet composition
2020 in colour, 2019 as the grey bar beneath
Assets €3.22M
Fixed assets €17k▼ 43.7%
Current assets €3.20M▲ 15.5%
Equity and liabilities €3.22M
Equity €1.49M▲ 13.6%
Provisions €4k▼ 54.5%
Debt €1.73M▲ 16.4%
The debt ratio rises from 53.0% to 53.7%: debt grows faster than equity.
Key figures and ratios
2020 value · change against 2019
EBITDA
€418k
2019 · €604k
Cash flow
€190k
2019 · €324k
Solvency
46.2%
2019 · 46.7%
Current ratio
1.86
2019 · 1.87
Quick ratio
1.47
2019 · 1.27
ROE
11.9%
2019 · 22.2%
ROA
5.5%
2019 · 10.4%
Interest coverage
27.21
2019 · 29.70
Debt
€1.73M
2019 · €1.48M
Debt ≤ 1 year
€1.72M
2019 · €1.48M
Income taxes
€86k
2019 · €153k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2020 against 2019
Balance sheet Code20192020
Assets
Total assets20/58€2.80M€3.22M
Fixed assets21/28€30k€17k
Intangible fixed assets21€8k€3k
Tangible fixed assets22/27€22k€14k
Financial fixed assets28€364€364=
Current assets29/58€2.77M€3.20M
Stocks and contracts in progress3€883k€681k
Amounts receivable within one year40/41€94k€22k
Cash at bank and in hand54/58€1.76M€2.49M
Equity and liabilities
Total equity and liabilities10/49€2.80M€3.22M
Equity10/15€1.31M€1.49M
Contributions10/11€100k€100k=
Reserves13€1.21M€1.39M
Profit (loss) carried forward14€2.01M€908k
Provisions and deferred taxes16€8k€4k
Amounts payable17/49€1.48M€1.73M
Amounts payable within one year42/48€1.48M€1.72M
Trade debts44€861k€1.23M
Income statement Code20192020
Turnover70€5.23M€5.82M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33k€13k
Operating profit (loss)9901€571k€405k
Recurring financial income75€309€80
Recurring financial charges65€127k€142k
Debt charges650€20k€15k
Profit (loss) for the period before taxes9903€444k€263k
Income taxes67/77€153k€86k
Profit (loss) for the period9904€290k€177k
Profit (loss) for the period to be appropriated9905€290k€177k

Download as CSV

Timeline · acts, filings and financial milestones

2021
26-07
State Gazette act Merger · Name change
Statutes amendment · Capital · Liesbet Degroote
25-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
27-04
State Gazette act Board meeting · Power of attorney
Merger · Accounting effect
2020
31-12
Financial Weakest financial yearnet €177k ▼38.9%
Net result drops to €177k, the lowest in the series.
31-05
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
16-05
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
23-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
24-05
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2016
10-06
NBB filing Annual accounts filed
fiscal year 2015 · full schema
2015
16-06
NBB filing Annual accounts filed
fiscal year 2014 · full schema
2014
04-07
NBB filing Annual accounts filed
fiscal year 2013 · full schema
2013
26-06
NBB filing Annual accounts filed
fiscal year 2012 · full schema
2012
31-05
NBB filing Annual accounts filed
fiscal year 2011 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Structure & network

Acquisitions and mergers

1 transaction
Taken over by:ACA PHARMA
BE 0416.616.681operation treated as a merger by absorption · State Gazette act of 26-07-2021 (2 acts)